Literature DB >> 28334444

The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.

Guido K W Frank1,2, Megan E Shott1, Jennifer O Hagman1, Marissa A Schiel1, Marisa C DeGuzman1,2, Brogan Rossi1.   

Abstract

OBJECTIVE: Finding medication to support treatment of anorexia nervosa has been difficult. Neuroscience-based approaches may help in this effort. Recent brain imaging studies in adults and adolescents with anorexia nervosa suggest that dopamine-related reward circuits are hypersensitive and could provide a treatment target.
METHODS: Here, we present a retrospective chart review of 106 adolescents with anorexia nervosa some of whom were treated with the dopamine D2 receptor partial agonist aripiprazole during treatment in a specialized eating disorder program.
RESULTS: The results show that aripiprazole treatment was associated with greater increase in body mass index (BMI) during treatment. DISCUSSION: The use of dopamine receptor agonists may support treatment success in anorexia nervosa and should be further investigated.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anorexia nervosa; aripiprazole; dopamine; eating disorder; medication; receptor; treatment; weight gain

Mesh:

Substances:

Year:  2017        PMID: 28334444      PMCID: PMC5392387          DOI: 10.1002/eat.22704

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  19 in total

1.  Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa.

Authors:  James Lock; Daniel Le Grange; W Stewart Agras; Ann Moye; Susan W Bryson; Booil Jo
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports.

Authors:  Mary Ellen Trunko; Terry A Schwartz; Vikas Duvvuri; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-04       Impact factor: 4.861

4.  A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.

Authors:  Jennifer Hagman; Jane Gralla; Eric Sigel; Swan Ellert; Mindy Dodge; Rick Gardner; Teri O'Lonergan; Guido Frank; Marianne Z Wamboldt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-08-05       Impact factor: 8.829

5.  Anorexia nervosa and obesity are associated with opposite brain reward response.

Authors:  Guido K W Frank; Jeremy R Reynolds; Megan E Shott; Leah Jappe; Tony T Yang; Jason R Tregellas; Randall C O'Reilly
Journal:  Neuropsychopharmacology       Date:  2012-05-02       Impact factor: 7.853

6.  Tolerability and efficacy of aripiprazole in a case of psychotic anorexia nervosa comorbid with epilepsy and chronic renal failure.

Authors:  M Aragona
Journal:  Eat Weight Disord       Date:  2007-09       Impact factor: 4.652

7.  Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice.

Authors:  Maria Ines Perez Millan; Guillermina Maria Luque; Maria Cecilia Ramirez; Daniela Noain; Ana Maria Ornstein; Marcelo Rubinstein; Damasia Becu-Villalobos
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

8.  Atypical antipsychotics as augmentation therapy in anorexia nervosa.

Authors:  Enrica Marzola; Nadia Desedime; Cristina Giovannone; Federico Amianto; Secondo Fassino; Giovanni Abbate-Daga
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

9.  The Perfect Storm - A Bio-Psycho-Social Risk Model for Developing and Maintaining Eating Disorders.

Authors:  Guido K W Frank
Journal:  Front Behav Neurosci       Date:  2016-03-10       Impact factor: 3.558

Review 10.  Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti; Felice Iasevoli
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

View more
  18 in total

1.  Psychotropic usage by patients presenting to an academic eating disorders program.

Authors:  Karuna Mizusaki; Daniel Gih; Christina LaRosa; Rebekah Richmond; Renee D Rienecke
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

2.  Dopaminergic activity and exercise behavior in anorexia nervosa.

Authors:  Sasha Gorrell; Anne G E Collins; Daniel Le Grange; Tony T Yang
Journal:  OBM Neurobiol       Date:  2020-03-23

Review 3.  Pharmacotherapy of eating disorders.

Authors:  Haley Davis; Evelyn Attia
Journal:  Curr Opin Psychiatry       Date:  2017-11       Impact factor: 4.741

Review 4.  The Neurobiology of Eating Disorders.

Authors:  Guido K W Frank; Megan E Shott; Marisa C DeGuzman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-07-04

5.  A2A Adenosine Receptor Partial Agonism Related to Structural Rearrangements in an Activation Microswitch.

Authors:  Matthew T Eddy; Bryan T Martin; Kurt Wüthrich
Journal:  Structure       Date:  2020-11-24       Impact factor: 5.006

Review 6.  Motivation to eat and not to eat - The psycho-biological conflict in anorexia nervosa.

Authors:  Guido K W Frank; Marisa C DeGuzman; Megan E Shott
Journal:  Physiol Behav       Date:  2019-04-10

Review 7.  Neuroimaging and eating disorders.

Authors:  Guido K W Frank
Journal:  Curr Opin Psychiatry       Date:  2019-11       Impact factor: 4.741

8.  A D2 to D1 shift in dopaminergic inputs to midbrain 5-HT neurons causes anorexia in mice.

Authors:  Xing Cai; Hailan Liu; Bing Feng; Meng Yu; Yang He; Hesong Liu; Chen Liang; Yongjie Yang; Longlong Tu; Nan Zhang; Lina Wang; Na Yin; Junying Han; Zili Yan; Chunmei Wang; Pingwen Xu; Qi Wu; Qingchun Tong; Yanlin He; Yong Xu
Journal:  Nat Neurosci       Date:  2022-05-02       Impact factor: 28.771

Review 9.  Canadian practice guidelines for the treatment of children and adolescents with eating disorders.

Authors:  Jennifer Couturier; Leanna Isserlin; Mark Norris; Wendy Spettigue; Melissa Brouwers; Melissa Kimber; Gail McVey; Cheryl Webb; Sheri Findlay; Neera Bhatnagar; Natasha Snelgrove; Amanda Ritsma; Wendy Preskow; Catherine Miller; Jennifer Coelho; Ahmed Boachie; Cathleen Steinegger; Rachel Loewen; Techiya Loewen; Elizabeth Waite; Catherine Ford; Kerry Bourret; Joanne Gusella; Josie Geller; Adele LaFrance; Anick LeClerc; Jennifer Scarborough; Seena Grewal; Monique Jericho; Gina Dimitropoulos; David Pilon
Journal:  J Eat Disord       Date:  2020-02-01

Review 10.  Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?

Authors:  Guido K W Frank
Journal:  Expert Opin Pharmacother       Date:  2020-04-13       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.